Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Delta Pathology is an independent, laboratory-professional-owned anatomic and clinical pathology group serving hospitals, physicians, and patients across parts of the southern United States. The company operates full-service pathology and laboratory offerings spanning surgical pathology, cytopathology, dermatopathology, hematopathology, gastrointestinal and liver pathology, breast pathology, renal pathology, blood banking, molecular diagnostics, genetic testing, and women's health testing. It also provides laboratory management and medical director services to hospital laboratories, with a stated focus on rapid turnaround times enabled by digital pathology infrastructure. Delta Pathology positions itself as a regional alternative to national reference laboratories and appears to be a mature, revenue-generating private healthcare services business rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Delta Pathology Group.